Literature DB >> 22414926

Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.

Zvi Laron1, Moshe Iluz, Rivka Kauli.   

Abstract

BACKGROUND: Head circumference (HC) is a simple and practical measure of brain size, development and longitudinal measurements of the HC in childhood are an index of brain growth.
OBJECTIVE: To determine the effects of long IGF-I deficiency and treatment on HC in patients with Laron syndrome (LS). PATIENTS: 20 untreated adult LS patients, aged 48.4±11.2 years and 13 LS patients treated between ages of 5.6±4 to 11.3±3 years were studied. 15 patients with congenital IGHD treated between age 6.1±4 and 13±4 by hGH served as controls.
METHODS: HC was expressed as standard deviation (SD) and Ht as SDS. HC was measured and plotted on Nellhaus charts. Linear height (Ht) was measured by a Harpenden Stadiometer.
CONCLUSIONS: The mean HC deficit of the adult untreated LS males was -2.9±0.6 SD compared to a Ht deficit of -7.0±1.7 SDS. The HC of the LS adult females was -3.6±1 SD compared to a Ht SDS of -6.9±1.5 (p<0.001). IGF-I treatment (150-200 μg/kg once daily) increased the HC from -3.3±0.9 (m±SD) to normal values (0.87±1.8 SD) (p<0.001) in 11/13 children. The Ht SDS deficit decreased only by 1.5 SDS. hGH treatment of cIGHD children increased the HC from -2.0±1.8 to 0.3±1.2 SD and the Ht SDS from -4.8±1.6 to 1.6±1.0.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414926     DOI: 10.1016/j.ghir.2012.02.005

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  5 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 2.  Early Programming by Protein Intake: The Effect of Protein on Adiposity Development and the Growth and Functionality of Vital Organs.

Authors:  Veronica Luque; Ricardo Closa-Monasterolo; Joaquín Escribano; Natalia Ferré
Journal:  Nutr Metab Insights       Date:  2016-03-20

3.  Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.

Authors:  Jürgen Klammt; David Neumann; Evelien F Gevers; Shayne F Andrew; I David Schwartz; Denise Rockstroh; Roberto Colombo; Marco A Sanchez; Doris Vokurkova; Julia Kowalczyk; Louise A Metherell; Ron G Rosenfeld; Roland Pfäffle; Mehul T Dattani; Andrew Dauber; Vivian Hwa
Journal:  Nat Commun       Date:  2018-05-29       Impact factor: 14.919

4.  Growth Hormone insensitivity (Laron syndrome): Report of a new family and review of Brazilian patients.

Authors:  Thais R Villela; Bruna L Freire; Nathalia T P Braga; Rodrigo R Arantes; Mariana F A Funari; Jorge A L Alexander; Ivani N Silva
Journal:  Genet Mol Biol       Date:  2020-01-20       Impact factor: 1.771

5.  Focal Epilepsy in Individuals with Laron Syndrome.

Authors:  Lotem Goldberg; Zvi Laron; Liora Kornreich; Oded Scheuerman; Hadassa Goldberg-Stern; Dror Kraus
Journal:  Horm Res Paediatr       Date:  2022-03-31       Impact factor: 4.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.